Pages that link to "Q37492248"
Jump to navigation
Jump to search
The following pages link to Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? (Q37492248):
Displaying 50 items.
- Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases (Q21285076) (← links)
- Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery (Q26749497) (← links)
- Genetics and biology of pancreatic ductal adenocarcinoma (Q26765438) (← links)
- T Cells and Cancer: How Metabolism Shapes Immunity (Q26766427) (← links)
- Targeting the indoleamine 2,3-dioxygenase pathway in cancer (Q26775471) (← links)
- The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy (Q26822976) (← links)
- Immunological aspect of pregnancy (Q26830251) (← links)
- Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship (Q27000087) (← links)
- Trial watch: IDO inhibitors in cancer therapy (Q27006866) (← links)
- Biochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogaster (Q27681115) (← links)
- Structural and functional analyses of human tryptophan 2,3-dioxygenase (Q27694654) (← links)
- Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases (Q27932755) (← links)
- Targeting immune checkpoints in malignant glioma (Q28072012) (← links)
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor (Q28249782) (← links)
- The Intercellular Metabolic Interplay between Tumor and Immune Cells (Q28391079) (← links)
- Plasma free amino acid profiling of five types of cancer patients and its application for early detection (Q28740654) (← links)
- The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells (Q28744405) (← links)
- The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways (Q33779682) (← links)
- An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function (Q33952214) (← links)
- A biological basis for depression in pancreatic cancer (Q33960726) (← links)
- Rebalancing Immune Specificity and Function in Cancer by T-Cell Receptor Gene Therapy (Q34084756) (← links)
- BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration. (Q34103836) (← links)
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase (Q34252356) (← links)
- Metabolomics for biomarker discovery in gastroenterological cancer (Q34318206) (← links)
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan (Q34319398) (← links)
- Analysis of lead toxicity in human cells (Q34354516) (← links)
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer (Q34414152) (← links)
- Trial Watch: Peptide-based anticancer vaccines (Q34483345) (← links)
- Substrate Oxidation by Indoleamine 2,3-Dioxygenase: EVIDENCE FOR A COMMON REACTION MECHANISM (Q34499772) (← links)
- Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds. (Q34616168) (← links)
- A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase (Q34631232) (← links)
- Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitro (Q34674972) (← links)
- Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction (Q35395398) (← links)
- Protein nitrotryptophan: formation, significance and identification (Q35421812) (← links)
- Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression (Q35583214) (← links)
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. (Q35677893) (← links)
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs (Q35757397) (← links)
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. (Q35799094) (← links)
- Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations. (Q35832639) (← links)
- Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation (Q35986384) (← links)
- Development of simultaneous analysis of tryptophan metabolites in serum and gastric juice - an investigation towards establishing a biomarker test for gastric cancer diagnosis (Q36033944) (← links)
- Several immune escape patterns in non-Hodgkin's lymphomas. (Q36060357) (← links)
- Resveratrol regulates naïve CD 8+ T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expression (Q36082436) (← links)
- A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. (Q36244860) (← links)
- Dynamic education of macrophages in different areas of human tumors (Q36284928) (← links)
- Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth (Q36476449) (← links)
- Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege (Q36899012) (← links)
- Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity (Q36922033) (← links)
- Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase (Q37017472) (← links)
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy (Q37079141) (← links)